Prestige Consumer Healthcare (PBH) EPS (Weighted Average and Diluted) (2010 - 2025)

Prestige Consumer Healthcare's EPS (Weighted Average and Diluted) history runs 16 years deep, the most recent figure standing at $0.97 for Q4 2025.

• In Q4 2025, EPS (Weighted Average and Diluted) fell 20.49% year-over-year to $0.97; the TTM figure through Dec 2025 stood at $3.79 (down 11.24% YoY), while the FY2025 annual figure was $4.29, up 2.88% from the prior year.
• EPS (Weighted Average and Diluted) was $0.97 for Q4 2025 at Prestige Consumer Healthcare, up from $0.86 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $1.22 in Q4 2024 to a low of -$4.79 in Q1 2023.
• Historically, EPS (Weighted Average and Diluted) has averaged $0.72 across 5 years, with a median of $1.02 in 2022.
• The sharpest annual moves came in 2023 and 2024: EPS (Weighted Average and Diluted) tumbled 569.61% in 2023, then soared 120.46% in 2024.
• A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.99 in 2021, then climbed by 5.05% to $1.04 in 2022, then increased by 1.92% to $1.06 in 2023, then increased by 15.09% to $1.22 in 2024, then decreased by 20.49% to $0.97 in 2025.
• The last three EPS (Weighted Average and Diluted) figures came in at $0.97 (Q4 2025), $0.86 (Q3 2025), and $0.95 (Q2 2025), per Business Quant data.